Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CMMB	CHEMOMAB THERAPEUTICS LTD	$10.56M	-89.90%	-75.70%	-89.80%	-217.80%	0.10	10.49	N/A	N/A	N/A
PYPD	POLYPID LTD	$67.94M	-312.80%	-120.70%	-134.93%	-203.00%	0.84	2.28	N/A	N/A	N/A
JANX	JANUX THERAPEUTICS INC	$830.04M	-10.20%	-9.80%	-10.22%	-11.40%	0.05	35.86	100.00%	-1,019.00%	-1,018.95%
HROW	HARROW INC	$1.81B	-9.00%	-1.40%	6.67%	9.40%	6.73	2.72	74.60%	-2.00%	7.95%
AGEN	AGENUS INC	$106.79M	N/A	-16.70%	-46.53%	346.20%	-1.88	0.47	98.90%	-33.10%	23.19%
MESO	MESOBLAST LTD	$2.31B	-19.00%	-14.10%	-11.56%	-103.10%	0.31	1.99	70.20%	-593.90%	-458.45%
ABT	ABBOTT LABORATORIES	$217.86B	28.10%	16.90%	12.42%	19.00%	0.64	1.70	55.90%	31.90%	19.72%
UPB	UPSTREAM BIO INC	$1.47B	-28.80%	-28.10%	-32.23%	-40.80%	0.03	32.67	100.00%	-4,386.40%	-4,366.77%
SABS	SAB BIOTHERAPEUTICS INC	$178.05M	33.40%	25.30%	11.00%	32.60%	0.11	10.50	100.00%	16,338.30%	16,554.61%
NRC	NATIONAL RESEARCH CORP	$425.28M	67.80%	12.00%	28.38%	27.80%	8.48	0.53	62.10%	11.80%	19.82%
INSM	INSMED INC	$37.12B	-183.60%	-54.60%	-56.31%	-53.90%	1.50	4.63	76.50%	-264.80%	-244.81%
GKOS	GLAUKOS CORP	$6.48B	-11.40%	-8.90%	-8.98%	-14.80%	0.30	5.20	76.90%	-18.60%	-17.42%
SMTI	SANARA MEDTECH INC	$208.65M	-127.50%	-42.30%	-58.21%	-53.10%	10.56	1.80	92.30%	-36.80%	-30.69%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$161.05M	N/A	N/A	N/A	N/A	-1.35	0.19	N/A	N/A	N/A
OFIX	ORTHOFIX MEDICAL INC	$600.33M	-25.60%	-14.10%	-13.42%	-17.40%	0.88	2.47	68.30%	-14.60%	-11.03%
MASS	908 DEVICES INC	$190.01M	-3.00%	-2.20%	-2.75%	-7.00%	0.40	3.49	49.20%	-7.20%	-7.12%
PRVA	PRIVIA HEALTH GROUP INC	$2.92B	2.70%	1.50%	4.20%	-279.10%	0.83	1.67	10.20%	0.90%	1.58%
GH	GUARDANT HEALTH INC	$12.87B	N/A	-29.30%	-37.91%	-23.20%	-4.60	3.50	63.80%	-44.20%	-43.68%
TECH	BIO-TECHNE CORP	$9.16B	3.90%	3.00%	4.82%	8.70%	0.29	4.22	65.40%	6.40%	9.43%
PACB	PACIFIC BIOSCIENCES OF CALIFORNIA INC	$564.57M	-289.50%	-53.70%	-66.93%	-45.80%	21.25	6.24	25.40%	-325.80%	-320.36%
GLTO	GALECTO INC	$30.54M	-130.70%	-111.30%	-195.32%	-1,211.70%	0.34	3.73	N/A	N/A	N/A
SPOK	SPOK HOLDINGS INC	$271.69M	11.00%	7.90%	13.77%	44.10%	0.41	1.21	79.30%	11.90%	15.82%
SLN	SILENCE THERAPEUTICS PLC	$286.90M	N/A	-38.10%	-52.83%	-97.50%	-0.98	7.69	90.50%	-255.10%	-261.96%
RLAY	RELAY THERAPEUTICS INC	$1.47B	-42.90%	-38.80%	-46.69%	-45.00%	0.10	19.14	100.00%	-3,561.40%	-3,561.43%
INGN	INOGEN INC	$182.44M	-13.20%	-8.30%	-10.78%	-25.80%	0.56	3.14	44.80%	-7.30%	-7.52%
CAMP	CAMP4 THERAPEUTICS CORP	$287.38M	-100.10%	-76.60%	-68.03%	-490.20%	0.47	9.83	100.00%	-1,404.50%	-1,404.47%
KZIA	KAZIA THERAPEUTICS LTD	$55.77M	N/A	-149.80%	280.88%	186.80%	-1.73	0.35	100.00%	-1,131.90%	-1,227.34%
MDWD	MEDIWOUND LTD	$236.68M	-62.10%	-27.10%	-24.94%	-55.90%	0.88	2.65	18.50%	-98.40%	-81.22%
LNSR	LENSAR INC	$138.92M	N/A	-73.70%	-149.46%	-190.00%	-3.18	1.24	46.10%	-87.10%	-87.14%
XNCR	XENCOR INC	$1.09B	-20.40%	-14.50%	-12.25%	-9.80%	0.39	6.00	100.00%	-87.10%	-63.85%
LXEO	LEXEO THERAPEUTICS INC	$724.76M	-90.50%	-70.90%	-82.85%	-112.40%	0.19	7.40	N/A	N/A	N/A
TDOC	TELADOC HEALTH INC	$1.24B	-15.60%	-7.00%	-9.24%	-19.60%	1.07	2.70	69.80%	-8.80%	-9.04%
NBY	NOVABAY PHARMACEUTICALS INC	$710.70M	113.90%	54.80%	159.05%	529.50%	1.67	2.00	54.60%	114.60%	114.59%
UNH	UNITEDHEALTH GROUP INC	$299.03B	18.60%	5.70%	12.74%	21.70%	2.19	0.82	19.70%	4.00%	5.85%
SCYX	SCYNEXIS INC	$26.52M	-54.30%	-37.40%	-58.43%	-52.10%	0.40	5.75	100.00%	-862.90%	-849.01%
ADMA	ADMA BIOLOGICS INC	$4.34B	54.00%	39.40%	32.05%	35.70%	0.32	7.13	54.70%	42.90%	33.60%
EKSO	EKSO BIONICS HOLDINGS INC	$22.66M	-90.70%	-42.20%	-80.33%	-86.10%	1.24	1.66	53.50%	-70.70%	-69.29%
IVA	INVENTIVA SA	$444.83M	N/A	-284.90%	-93.27%	-121.40%	-21.09	2.96	100.00%	-1,767.30%	-638.55%
NVCR	NOVOCURE LTD	$1.45B	-50.30%	-13.90%	-30.20%	-17.00%	2.99	1.55	75.40%	-27.70%	-27.51%
CORT	CORCEPT THERAPEUTICS INC	$3.66B	15.90%	12.60%	9.84%	11.20%	0.30	3.14	98.20%	14.10%	8.65%
OKYO	OKYO PHARMA LTD	$77.85M	N/A	-180.40%	127.79%	102.70%	-1.66	0.40	N/A	N/A	N/A
LBRX	LB PHARMACEUTICALS INC	$563.16M	N/A	N/A	N/A	N/A	0.03	47.60	N/A	N/A	N/A
PRTA	PROTHENA CORP PUBLIC LTD CO	$514.08M	-72.70%	-62.50%	-79.27%	-3,639.10%	0.20	6.61	100.00%	-2,379.60%	-2,025.72%
ICLR	ICON PLC	$13.91B	6.30%	3.60%	6.18%	18.50%	0.77	1.06	28.10%	7.40%	10.13%
EOLS	EVOLUS INC	$431.05M	N/A	-26.20%	-24.65%	-22.30%	-8.62	2.02	65.80%	-20.50%	-13.13%
CSTL	CASTLE BIOSCIENCES INC	$1.14B	-2.70%	-2.30%	-3.70%	-5.70%	0.21	6.47	79.90%	-3.60%	-5.46%
NVO	NOVO NORDISK A S	$226.09B	67.00%	21.30%	47.46%	56.40%	2.02	0.78	82.00%	32.90%	41.80%
SIGA	SIGA TECHNOLOGIES INC	$437.55M	35.30%	31.10%	46.88%	213.10%	0.14	9.17	76.30%	43.20%	56.27%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$49.61B	0.50%	0.20%	3.00%	4.50%	1.03	1.37	64.60%	0.70%	8.37%
RLMD	RELMADA THERAPEUTICS INC	$354.20M	-269.50%	-205.20%	-579.92%	-296.10%	0.57	2.86	N/A	N/A	N/A
PLX	PROTALIX BIOTHERAPEUTICS INC	$144.76M	11.30%	7.00%	12.37%	18.00%	0.56	3.03	57.50%	8.70%	12.06%
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$157.65M	N/A	N/A	N/A	N/A	0.22	5.48	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$14.74B	N/A	-82.20%	-86.24%	-30.80%	-1.51	3.88	95.80%	-225.30%	-190.53%
CGEN	COMPUGEN LTD	$143.11M	-53.60%	-25.40%	-35.53%	-123.40%	1.23	4.38	7.40%	-400.10%	-399.26%
TCRX	TSCAN THERAPEUTICS INC	$56.75M	-73.90%	-45.10%	-59.97%	-67.10%	0.82	6.44	100.00%	-1,693.00%	-1,659.11%
UNCY	UNICYCIVE THERAPEUTICS INC	$124.01M	-184.40%	-95.50%	-89.14%	368.10%	0.35	3.83	N/A	N/A	N/A
USPH	U S PHYSICAL THERAPY INC	$1.19B	9.00%	3.80%	6.82%	15.50%	0.82	1.20	18.70%	5.90%	9.71%
NUVB	NUVATION BIO INC	$3.07B	-55.00%	-38.10%	-39.44%	-42.00%	0.85	8.48	54.30%	-813.10%	-786.53%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$65.72M	-316.10%	-176.10%	-1,881.63%	435.00%	3.23	1.21	N/A	N/A	N/A
NIVF	NEWGENIVF GROUP LTD	$297.07k	N/A	N/A	N/A	N/A	0.23	3.43	N/A	N/A	N/A
SLS	SELLAS LIFE SCIENCES GROUP INC	$537.01M	-95.20%	-75.10%	-56.85%	1,520.90%	0.13	8.28	N/A	N/A	N/A
TTRX	TURN THERAPEUTICS INC	$116.01M	N/A	N/A	N/A	N/A	7.53	1.43	N/A	N/A	N/A
MDGL	MADRIGAL PHARMACEUTICALS INC	$13.23B	-41.50%	-26.20%	-27.97%	-32.00%	1.18	3.44	95.30%	-39.00%	-36.67%
LMRI	LUMEXA IMAGING HOLDINGS INC	N/A	N/A	N/A	N/A	N/A	9.11	0.92	N/A	N/A	N/A
LNTH	LANTHEUS HOLDINGS INC	$4.41B	14.80%	8.00%	13.60%	22.30%	1.03	2.67	62.20%	11.00%	17.19%
CRON	CRONOS GROUP INC	$1.01B	3.40%	3.10%	-0.57%	-2.60%	0.04	22.46	43.40%	27.30%	-4.88%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$10.38B	-54.80%	-50.50%	-70.39%	-83.50%	0.18	7.39	N/A	N/A	N/A
GRAL	GRAIL INC	$3.34B	-17.20%	-14.60%	-21.60%	-81.80%	0.16	7.61	-47.50%	-286.40%	-384.26%
IONS	IONIS PHARMACEUTICALS INC	$12.81B	-44.30%	-8.70%	-7.89%	-4.80%	3.91	2.79	98.80%	-26.50%	-17.37%
LEGN	LEGEND BIOTECH CORP	$4.02B	-23.40%	-14.30%	-15.74%	-27.80%	0.69	2.87	60.60%	-26.40%	-22.16%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$956.94M	-32.10%	-28.20%	-31.77%	-35.90%	0.14	8.68	89.40%	-113.50%	-108.69%
XGN	EXAGEN INC	$137.79M	-138.20%	-36.90%	-30.92%	-39.40%	2.46	4.08	59.90%	-29.90%	-24.27%
ONMD	ONEMEDNET CORP	$56.11M	N/A	-87.50%	55.64%	34.20%	-1.38	0.29	-144.00%	-411.10%	-393.33%
ACHC	ACADIA HEALTHCARE COMPANY INC	$1.31B	3.50%	1.70%	4.43%	4.70%	1.00	1.44	34.40%	3.30%	7.99%
NXTC	NEXTCURE INC	$38.03M	-132.90%	-98.60%	-202.71%	-149.10%	0.68	2.97	N/A	N/A	N/A
URGN	UROGEN PHARMA LTD	$1.10B	N/A	-71.00%	-102.36%	-74.20%	-2.60	3.99	88.00%	-170.60%	-151.45%
KURA	KURA ONCOLOGY INC	$904.11M	-65.40%	-30.60%	-40.35%	-41.40%	1.68	5.12	100.00%	-208.50%	-204.82%
NOTV	INOTIV INC	$19.31M	-45.20%	-8.90%	-14.55%	-5.00%	4.67	0.35	23.60%	-13.40%	-6.08%
ATNM	ACTINIUM PHARMACEUTICALS INC	$42.43M	-151.70%	-52.30%	-70.16%	1,172.70%	3.07	7.96	100.00%	-38,443.30%	-38,443.33%
RAPT	RAPT THERAPEUTICS INC	$938.57M	-61.80%	-54.70%	-69.33%	-107.60%	0.09	12.04	N/A	N/A	N/A
SGRY	SURGERY PARTNERS INC	$2.00B	-9.80%	-2.20%	2.88%	3.70%	2.78	1.88	23.90%	-5.20%	6.44%
NNNN	ANBIO BIOTECHNOLOGY	$4.33B	11.20%	11.00%	9.34%	17.00%	0.01	211.10	89.70%	37.20%	37.20%
TEM	TEMPUS AI INC	$10.51B	-68.00%	-12.80%	-9.38%	-15.10%	3.49	3.28	61.70%	-18.40%	-16.39%
HRTX	HERON THERAPEUTICS INC	$238.37M	N/A	-5.70%	-6.97%	-4.50%	15.73	2.56	73.90%	-8.80%	-7.15%
CBLL	CERIBELL INC	$813.51M	-29.60%	-24.80%	-27.41%	-43.40%	0.22	12.65	88.00%	-63.30%	-61.02%
TLRY	TILRAY BRANDS INC	$1.01B	-93.00%	-73.30%	-123.96%	-196.00%	0.37	2.62	28.70%	-259.10%	-270.82%
PVLA	PALVELLA THERAPEUTICS INC	$1.24B	-68.50%	-45.50%	-49.43%	433.60%	0.73	6.49	100.00%	66,162.30%	52,807.55%
FGEN	FIBROGEN INC	$35.52M	-126.40%	124.20%	213.12%	161.40%	-7.02	3.71	82.70%	-182.60%	-182.34%
CRVS	CORVUS PHARMACEUTICALS INC	$575.05M	-25.80%	-20.20%	-20.82%	-28.70%	0.12	8.29	N/A	N/A	N/A
RDNT	RADNET INC	$5.50B	-1.30%	-0.40%	2.01%	2.00%	2.22	1.88	11.40%	-0.60%	3.15%
CTOR	CITIUS ONCOLOGY INC	$84.80M	-64.20%	-26.40%	-45.65%	-49.40%	1.25	0.56	N/A	N/A	N/A
HYFT	MINDWALK HOLDINGS CORP	$84.01M	-136.90%	-76.10%	-155.54%	-149.70%	0.47	4.19	58.50%	-146.10%	-159.30%
HCAT	HEALTH CATALYST INC	$169.05M	-30.30%	-14.60%	-18.48%	-35.40%	0.77	1.88	46.50%	-34.10%	-29.19%
DARE	DARE BIOSCIENCE INC	$27.58M	N/A	-82.70%	-183.21%	165.90%	9.76	1.18	-44.70%	30,568.80%	30,568.80%
ABUS	ARBUTUS BIOPHARMA CORP	$925.08M	-50.20%	-37.60%	-45.57%	-57.70%	0.26	18.80	100.00%	-289.40%	-288.70%
PROF	PROFOUND MEDICAL CORP	$237.62M	-96.60%	-79.10%	-137.14%	-335.10%	0.32	4.18	71.80%	-318.90%	-321.05%
CCRN	CROSS COUNTRY HEALTHCARE INC	$265.36M	-3.80%	-2.80%	-3.08%	-6.80%	0.32	3.45	20.20%	-1.40%	-1.23%
QTTB	Q32 BIO INC	$40.85M	N/A	-57.00%	-90.15%	-269.00%	-4.13	4.57	N/A	N/A	N/A
SEER	SEER INC	$102.09M	-26.50%	-23.60%	-26.94%	-26.10%	0.14	14.25	50.70%	-484.50%	-482.85%
BDSX	BIODESIX INC	$54.10M	-504.40%	-43.90%	-45.53%	-31.60%	-52.52	1.84	79.80%	-49.30%	-40.07%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	615	+0.27%	-2.56%	+0.97%	-41.73%	146.65x	5.25x	-24.86%	-9.63%	-5.94%	+53.28%	Strong Buy
Diagnostics & Research	57	-0.98%	-1.53%	-3.92%	+15.95%	22.62x	4.43x	-1.14%	+6.19%	+13.13%	+8.73%	Buy
Drug Manufacturers - General	20	-0.36%	-0.64%	+0.75%	+29.59%	46.13x	6.93x	+106.72%	+12.28%	+20.38%	+4.48%	Buy
Drug Manufacturers - Specialty & Generic	77	-0.56%	-2.69%	+2.08%	-2.13%	-31.58x	2.36x	+9.51%	+2.96%	+5.96%	+55.56%	Strong Buy
Healthcare Plans	10	-0.12%	+1.21%	+5.01%	-15.66%	43.65x	2.07x	+12.19%	+3.78%	+9.23%	+14.08%	Buy
Health Information Services	54	-1.69%	-1.94%	-3.58%	-49.84%	42.11x	3.83x	+8.87%	+4.67%	+6.54%	+39.06%	Strong Buy
Medical Care Facilities	50	-1.25%	-1.53%	-4.54%	-42.75%	15.02x	5.23x	-80.60%	+7.33%	+16.04%	+20.06%	Buy
Medical Devices	139	+0.40%	-1.57%	-14.79%	-92.02%	23.79x	3.87x	+11.80%	+7.14%	+8.17%	+38.40%	Strong Buy
Medical Distribution	10	-0.79%	-0.70%	-3.80%	+44.38%	31.24x	3,562.64x	-56.46%	+3.41%	+21.83%	+9.05%	Buy
Medical Instruments & Supplies	57	-0.94%	-1.78%	+0.33%	-31.91%	222.67x	3.29x	+10.08%	+8.62%	+11.38%	+15.84%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jan 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #1 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 38, which is 12 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock lose -23.93% over the past year, overperforming other healthcare stocks by 39 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $3.00, a downside of -10.98% from Ironwood Pharmaceuticals's current stock price of $3.37.

Ironwood Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #2 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 63.03% over the past year, overperforming other healthcare stocks by 126 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -0.27% from Pediatrix Medical Group's current stock price of $21.39.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: A.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 29, which is 3 points higher than the healthcare sector average of 26. It passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 75.56% over the past year, overperforming other healthcare stocks by 138 percentage points.

What are the healthcare stocks with highest dividends?

Out of 69 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.91%, which is 9 percentage points higher than the healthcare sector average of 1.92%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.48%, which is 8 percentage points higher than the healthcare sector average of 1.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 5.6%, which is 4 percentage points higher than the healthcare sector average of 1.92%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.6% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and down -1.76% over the last week. Corcept Therapeutics was the among the top losers in the healthcare sector, dropping -50.42% yesterday.

Corcept Therapeutics shares are trading lower after the company announced it received a Complete Response Letter for Relacorilant from the FDA.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -51.94% in the past year. It has overperformed other stocks in the healthcare sector by 11 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 8.75% in the past year. It has overperformed other stocks in the healthcare sector by 71 percentage points.

3. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -13.77% in the past year. It has overperformed other stocks in the healthcare sector by 49 percentage points.

Are healthcare stocks a good buy now?

57.52% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 31.56% over the next year.

7.72% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.81% of healthcare stocks are rated B (Buy), 47.84% are rated C (Hold), 24.68% are rated D (Sell), and 7.95% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 62.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.